SCHEMBL14554131

SCHEMBL14554131

Cc1cc(Cl)cc(Cl)c1OC(=O)CC(=O)Oc1c(Cl)cc(Cl)cc1Cl

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.47
TDP1 Q9NUW8 1/20 0.45
MRGPRX4 Q96LA9 1/20 0.45
ALDH1A1 P00352 4/20 0.44
MAPT P10636 3/20 0.44
POLB P06746 2/20 0.44
USP2 O75604 1/20 0.44
LMNA P02545 1/20 0.44
HPGD P15428 1/20 0.44
ALOX15 P16050 1/20 0.44
TSHR P16473 1/20 0.44
ALOX12 P18054 1/20 0.44
ATM Q13315 1/20 0.44
HSD17B10 Q99714 1/20 0.44
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42
HIF1A Q16665 1/20 0.42
ABCB1 P08183 1/20 0.41
RAPGEF4 Q8WZA2 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL348786 0.89 CA1 (0.41) KDM4ETDP1ALDH1A1MAPTTSHR
SCHEMBL14305007 0.88 RAPGEF4 (0.41) KDM4ETDP1MRGPRX4ALDH1A1MAPT
SCHEMBL14311187 0.81 CA1 (0.35) KDM4ETDP1ALDH1A1MAPTPOLB
SCHEMBL8525341 0.80 TDP1 (0.40) KDM4ETDP1MRGPRX4ALDH1A1MAPT
SCHEMBL27749907 0.80 KDM4E (0.47) KDM4ETDP1MRGPRX4ALDH1A1MAPT
SCHEMBL4642241 0.76 CA1 (0.39) KDM4ETDP1MRGPRX4ALDH1A1TSHR
SCHEMBL4642299 0.76 ALDH1A1 (0.41) KDM4ETDP1ALDH1A1LMNATSHR
SCHEMBL4641646 0.74 CA1 (0.38) KDM4ETDP1MRGPRX4ALDH1A1MAPT
SCHEMBL15131812 0.74 MIF (0.43) KDM4EALDH1A1LMNATSHRATM
SCHEMBL10981786 0.73 CYP1A2 (0.45) KDM4ETDP1ALDH1A1MAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8785452-B2 Anti-infective compounds INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR) 2014-07-22 US disclosed
US-20130012506-A1 ANTI-INFECTIVE PYRIDO (1,2-A) PYRIMIDINES NO ZAESUNG (KR) 2013-01-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130012506-A1 ANTI-INFECTIVE PYRIDO (1,2-A) PYRIMIDINES TYMS, TYMP, DCTPP1 KDM4E 4036/4885TDP1 507/4885MRGPRX4 2233/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.